The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Camille N. Kotton, Deepali Kumar, Angela M. Caliendo, Shirish Huprikar, Sunwen Chou, Lara Danziger-Isakov, Atul Humar

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.

Original languageEnglish (US)
Pages (from-to)900-931
Number of pages32
JournalTransplantation
Volume102
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Organ Transplantation
Cytomegalovirus
Consensus
Guidelines
Transplants
Molecular Pathology
Cytomegalovirus Infections
Expert Testimony
Immunosuppressive Agents
Allergy and Immunology
Drug Resistance
Antiviral Agents
Therapeutics
Pediatrics
Morbidity
Mortality
Research

ASJC Scopus subject areas

  • Transplantation

Cite this

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. / Kotton, Camille N.; Kumar, Deepali; Caliendo, Angela M.; Huprikar, Shirish; Chou, Sunwen; Danziger-Isakov, Lara; Humar, Atul.

In: Transplantation, Vol. 102, No. 6, 01.06.2018, p. 900-931.

Research output: Contribution to journalArticle

Kotton, CN, Kumar, D, Caliendo, AM, Huprikar, S, Chou, S, Danziger-Isakov, L & Humar, A 2018, 'The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation', Transplantation, vol. 102, no. 6, pp. 900-931. https://doi.org/10.1097/TP.0000000000002191
Kotton, Camille N. ; Kumar, Deepali ; Caliendo, Angela M. ; Huprikar, Shirish ; Chou, Sunwen ; Danziger-Isakov, Lara ; Humar, Atul. / The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. In: Transplantation. 2018 ; Vol. 102, No. 6. pp. 900-931.
@article{6c32facce08841da8ef7886170efe7e6,
title = "The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation",
abstract = "Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.",
author = "Kotton, {Camille N.} and Deepali Kumar and Caliendo, {Angela M.} and Shirish Huprikar and Sunwen Chou and Lara Danziger-Isakov and Atul Humar",
year = "2018",
month = "6",
day = "1",
doi = "10.1097/TP.0000000000002191",
language = "English (US)",
volume = "102",
pages = "900--931",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

AU - Kotton, Camille N.

AU - Kumar, Deepali

AU - Caliendo, Angela M.

AU - Huprikar, Shirish

AU - Chou, Sunwen

AU - Danziger-Isakov, Lara

AU - Humar, Atul

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.

AB - Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.

UR - http://www.scopus.com/inward/record.url?scp=85046370425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046370425&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000002191

DO - 10.1097/TP.0000000000002191

M3 - Article

C2 - 29596116

AN - SCOPUS:85046370425

VL - 102

SP - 900

EP - 931

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -